Form 4: Carlyle Group Entities Report Sale of 8.26 Million QuidelOrtho Shares
SEC Form 4 Filing
Carlyle Group and related entities have reported the sale of 8,260,183 shares of QuidelOrtho Corp at a price of $35.314 per share.
Summary
- Carlyle Group Inc. and several related entities have filed a Form 4 with the SEC, disclosing the sale of 8,260,183 shares of QuidelOrtho Corp common stock.
- The transaction occurred on November 21, 2024, with the shares being sold at a price of $35.314 each.
- The shares were indirectly held through a complex structure of entities, ultimately owned by Carlyle Partners VI Cayman Holdings, L.P.
- The filing indicates that while these entities may be deemed to share beneficial ownership, they disclaim such ownership.
Sentiment
Score: 5
Explanation: The document is a neutral report of a share sale. It doesn't indicate positive or negative sentiment, but rather a factual transaction.
Risks
- The sale of a large block of shares by a major shareholder like Carlyle Group could potentially put downward pressure on the stock price.
- The complex ownership structure may raise questions about the ultimate control and intentions of the various entities involved.
Management Comments
- The Carlyle Group Inc. disclaims beneficial ownership of the securities.
- Each of the related entities disclaims beneficial ownership of the securities.
Industry Context
This transaction is a significant ownership change for QuidelOrtho Corp, a company in the healthcare diagnostics sector. Large block trades by institutional investors can often signal shifts in market sentiment or strategic repositioning.
Comparison to Industry Standards
- Large institutional investors like Carlyle Group often adjust their holdings based on their investment strategies and market conditions.
- Similar transactions are common in the market, with other private equity firms and investment funds regularly adjusting their positions in publicly traded companies.
- The size of this transaction is significant, but not unusual for a major shareholder.
Stakeholder Impact
- The sale of a large block of shares could potentially impact the share price of QuidelOrtho Corp, affecting shareholders.
- The transaction may also be of interest to other institutional investors and market analysts.
Key Dates
| Date | Description |
|---|---|
| 11/21/2024 | Date of the share sale transaction. |
Keywords
Carlyle Group, QuidelOrtho Corp, Share Sale, SEC Form 4, Beneficial Ownership, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.